Simplify Asset Management’s ResMed RMD Stock Holding History

Simplify Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,005	Closed	-$2.58M	–	137
2025 Q2	$2.58M	Sell	10,005 -1,096	-10%	-$261K	0.13%	37
2025 Q1	$2.48M	Sell	11,101 -19,040	-63%	-$4.44M	0.09%	38
2024 Q4	$6.89M	Buy	+30,141	New	+$7.26M	0.34%	19
2024 Q1	–	Sell	-1,812	Closed	-$312K	–	136
2023 Q4	$312K	Buy	+1,812	New	+$278K	0.03%	101
2023 Q2	–	Sell	-3,572	Closed	-$782K	–	136
2023 Q1	$782K	Sell	3,572 -6,097	-63%	-$1.32M	0.11%	68
2022 Q4	$2.01M	Buy	9,669 +777	+9%	+$171K	0.31%	30
2022 Q3	$1.94M	Buy	8,892 +2,775	+45%	+$632K	0.21%	28
2022 Q2	$1.28M	Buy	+6,117	New	+$1.3M	0.05%	31

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Simplify Asset Management's RMD Position: Q3 2025 in Review

Simplify Asset Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 10,005 shares — an estimated $2.58M sold.

Simplify Asset Management first reported a position in RMD in Q2 2022 and held it in 8 quarters. The position peaked at $6.89M in Q4 2024. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Simplify Asset Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Simplify Asset Management sold 10,005 ResMed shares in Q3 2025, an estimated $2.58M.
Simplify Asset Management first reported a position in ResMed in Q2 2022 and held it in 8 quarters.
Simplify Asset Management's ResMed position peaked at $6.89M in Q4 2024.
949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Simplify Asset Management's 13F filing for Q3 2025, filed 20 Oct 2025.